Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and Health Technology Assessment, UMIT-University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.
Faculty of Pharmacy, School of PhD Studies, Ss. Cyril and Methodius University, Skopje, Macedonia.
Thyroid. 2021 Apr;31(4):649-657. doi: 10.1089/thy.2020.0065. Epub 2020 Oct 21.
Although substantial progress has been made in recent decades in eliminating iodine deficiency, iodine deficiency disorders (IDDs) are still prevalent in European countries. Challenges include ineffective public health programs and discontinuation of IDD prevention. However, the barriers against the implementation and continuation of prevention and monitoring of IDD remain unclear. Therefore, the objective of our study was to identify potential barriers against pan-European IDD prevention and monitoring programs and to find solutions for the different challenges. We conducted a Delphi study consisting of three rounds. We identified potential participants with expertise and experience in relevant fields from all European countries, including policy makers, health care professionals, health scientists, and patient representatives. The Delphi method was conducted with open-ended questions and item ranking to achieve group consensus on potential barriers against national and pan-European IDD prevention and monitoring programs and related solutions to overcome those barriers. The answers of the Delphi rounds were analyzed using qualitative content analysis and descriptive analysis methods. In addition, we conducted two expert interviews to analyze and discuss the study results. Eighty experts from 36 countries and different fields of work participated in the first Delphi round, 52 in the second, and 46 in the third. Potential barriers include challenges in the fields of knowledge and information, implementation and management, communication and cooperation, political support, and differences between the European countries. Ranked solutions addressing these barriers include cooperation with different stakeholders, gaining knowledge, sharing information, the development of a European program with national specification, European guidelines/recommendations, and European monitoring. The ranking gives a first overview as to which of these barriers would need to be solved most urgently and which solutions may be most helpful. In our study, we derived key information and first insights with regard to barriers against IDD prevention programs from a broad range of stakeholders. Most barriers were found in the category of implementation and management. Also a lack of political support seems to play an important role. The findings of our study may help decision makers in health policy to develop more effective IDD prevention and monitoring strategies.
尽管在过去几十年中,消除碘缺乏症方面取得了重大进展,但碘缺乏症(IDD)在欧洲国家仍然普遍存在。面临的挑战包括公共卫生计划效果不佳和 IDD 预防措施的停止。然而,实施和继续预防和监测 IDD 的障碍尚不清楚。因此,我们的研究目的是确定泛欧 IDD 预防和监测计划的潜在障碍,并为不同的挑战找到解决方案。
我们进行了一项由三回合组成的德尔菲研究。我们从所有欧洲国家中具有相关领域专业知识和经验的潜在参与者中确定了潜在的参与者,包括政策制定者、医疗保健专业人员、健康科学家和患者代表。德尔菲法采用开放式问题和项目排名,以就国家和泛欧 IDD 预防和监测计划的潜在障碍以及克服这些障碍的相关解决方案达成小组共识。使用定性内容分析和描述性分析方法对德尔菲回合的答案进行分析。此外,我们进行了两次专家访谈,以分析和讨论研究结果。
来自 36 个国家和不同工作领域的 80 名专家参加了第一轮德尔菲调查,52 名参加了第二轮,46 名参加了第三轮。潜在的障碍包括知识和信息、实施和管理、沟通与合作、政治支持以及欧洲国家之间差异等领域的挑战。针对这些障碍的排名解决方案包括与不同利益相关者合作、获取知识、共享信息、制定具有国家规范的欧洲计划、欧洲准则/建议以及欧洲监测。排名提供了一个初步概述,即需要解决哪些障碍最紧迫,哪些解决方案最有帮助。
在我们的研究中,我们从广泛的利益相关者那里获得了有关 IDD 预防计划障碍的关键信息和初步见解。大多数障碍存在于实施和管理类别中。政治支持的缺乏似乎也起着重要作用。我们的研究结果可能有助于卫生政策决策者制定更有效的 IDD 预防和监测策略。